NCT01626352 Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy Status COMPLETED Phase PHASE2
NCT01623349 Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01623167 Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01621204 A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients Status COMPLETED Phase PHASE3
NCT01616186 Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Status WITHDRAWN Phase PHASE2
NCT01613677 Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer Status WITHDRAWN Phase PHASE2
NCT01610206 A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01595984 Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) Status UNKNOWN Phase PHASE3
NCT01593748 A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT01591577 Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT01589029 A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) Status TERMINATED Phase PHASE1
NCT01586962 Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI Status COMPLETED Phase PHASE3
NCT01582009 Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate Status TERMINATED Phase PHASE1/PHASE2
NCT01576809 Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI) Status COMPLETED Phase PHASE3
NCT01570296 A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR Status COMPLETED Phase PHASE1
NCT01568775 Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects Status COMPLETED Phase PHASE1
NCT01566747 Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 Status COMPLETED Phase PHASE2
NCT01564108 The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema Status COMPLETED Phase PHASE2